All News #Library
Rare Diseases
RESTEM Initiates Phase 2/3 IIMPACT Study Of Restem-L
03 Feb 2026 //
GLOBENEWSWIRE
Restem Doses First FSHD Patient in Phase 1/2a Restem-L Study
08 Dec 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support